§ Mr. Mike Thomasasked the Secretary of State for Social Services what proportion of pharmaceutical companies' turnover calculated on the same basis as his agreement with the pharmaceutical com-
666W
§ Mr. MoyleIn 1976, the latest date for which figures are at present available, the relevant information for England was as follows:
panies to reduce promotional expenditure was expended on clinical trials involving general practitioners and over 5,000 patients in the latest available period.
§ Mr. MoyleI regret that this information is not available. Expenditure on clinical trials is not distinguished from expenditure on other research and development in the audited annual financial returns which pharmaceutical companies make to my Department under the Pharmaceutical Price Regulation Scheme.